Blueprint Fitness - Training Status
- $720.96
- $174.95
- Save: 75.73%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Cortisol Total, Hydrocortisone, Total Cortisol
Cortisol, Total
Also known as: CK (Total), CPK, CPK (Total), Creatine Kinase CK Total, Creatine Phosphokinase (CPK), Total CK
Creatine Kinase, Total
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Hs Crp
Immunoglobulin A
Also known as: Iron and TIBC, Iron and Total Iron Binding Capacity TIBC, TIBC
% Saturation
Iron Binding Capacity
Iron, Total
Also known as: Testosterone Total And Free And Sex Hormone Binding Globulin
Free Testosterone
Sex Hormone Binding
TESTOSTERONE, TOTAL,
Transferrin
Also known as: Thyroid Stimulating Hormone, Thyroid Stimulating Hormone (TSH), Thyrotropin
TSH
TSH
The Blueprint Fitness - Training Status panel contains 8 tests with 13 biomarkers .
Excellent For:
- Anabolic Optimization
- Endurance Training
- Functional Fitness
- Recovery
- Strength Training
The Blueprint Fitness - Training Status panel contains the following biomarkers.
- C-Reactive Protein (hs-CRP)
- Cortisol
- Creatine Kinase (CK)
- Immunoglobulin A (IgA)
- Iron
- Percent (%) Saturation
- Sex hormone binding globulin
- Testosterone
- Testosterone - Cortisol (T-C) Ratio
- Testosterone.free
- Thyroid Stimulating Hormone (TSH)
- Total Iron Binding Capacity (TIBC)
- Transferrin
This panel also provides the 10-year and lifetime risk of ASCVD events and the 8-year risk of developing diabetes. The lipid panel results will aid in the assessment of ASCVD. Assessment of 10-year risk of a first atherosclerotic cardiovascular (ASCVD) event is recommended by the 2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. These guidelines recommend initiating statin therapy based on 10-year ASCVD risk score. Assessment of 8-year risk of developing diabetes mellitus is based on laboratory test results with anthropomorphic data and family history. This algorithm was developed in the Framingham cohort, and is intended to aid in the identification of patients at risk for developing diabetes, permitting pharmacological or lifestyle interventions.
IMPORTANT: For risk calculations to be performed, the following patient-specific information must be provided and recorded at the time of specimen collection:
- Age: Years
- Gender: M (for male) or F (for female)
- Height Feet: Feet
- Height Inches: Inches
- Weight: lbs
- Race-African American: Y (for yes) or N (for no)
- Systolic Blood Pressure: mmHg
- Diastolic Blood Pressure: mmHg
- Treatment for High B.P.: Y (for yes) or N (for no)
- Diabetes Status: Y (for yes) or N (for no)
- Parental History of Diab: Y (for yes) or N (for no)
- Smoking Status: Y (for Yes) or N (for no)